Eslamian Mohammad, Sheikhbahaei Erfan, Esparham Ali, Zefreh Hamidreza, Fasahat Amirhossein, Firouzfar Alireza, Talebzadeh Hamid
Department of Surgery, School of Medicine.
Isfahan Minimally Invasive Surgery and Obesity Research Center, Alzahra University Hospital, School of Medicine.
Ann Med Surg (Lond). 2024 Jul 31;86(10):5830-5836. doi: 10.1097/MS9.0000000000002338. eCollection 2024 Oct.
This study aims to examine the effects of preperitoneal administration of dexamethasone and bupivacaine surrounding laparoscopic trocars on postoperative pain (POP) and nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy (LC).
In this randomized triple-blinded trial with a 1:1 randomization ratio, 104 patients with chronic cholecystitis were candidates for elective LC. A total of 40 mg (8 ml) of bupivacaine was mixed with 8 mg (2 ml) of dexamethasone or normal saline. The solution was injected preperitoneally via an 18G needle parallel and lateral to trocars until a bulge in the interior surface of the parietal peritoneum was observed by the camera. Primary outcomes were the severity of POP based on 0-10 Likert visual analog scale (VAS) and rates of PONV and secondary outcomes were rate of postoperative opioid usage and any side-effects.
The mean VAS score was significantly lower in the dexamethasone group (3.5 vs. 6.2, <0.001). The dexamethasone group had 46.2% and 26.9% lower rates of nausea and vomiting after LC compared to the other group (=0.001 and 0.015, respectively). Postoperative opioid use was lower in the dexamethasone group, but its difference was insignificant (=0.3).
Preperitoneal dexamethasone injection around laparoscopic trocars may lower the intensity of POP and PONV rates. Perioperative local corticosteroids can be used as an effective, available, and inexpensive analgesic and antiemetic prevention for laparoscopic procedures.
本研究旨在探讨腹腔镜胆囊切除术(LC)患者术中在腹腔镜套管针周围腹膜前注射地塞米松和布比卡因对术后疼痛(POP)及恶心呕吐(PONV)的影响。
在这项随机比例为1:1的三盲试验中,104例慢性胆囊炎患者拟行择期LC。将40mg(8ml)布比卡因与8mg(2ml)地塞米松或生理盐水混合。通过18G针头在套管针平行外侧腹膜前注射该溶液,直至腹腔镜观察到腹膜内表面有隆起。主要结局指标为基于0 - 10李克特视觉模拟量表(VAS)的POP严重程度以及PONV发生率,次要结局指标为术后阿片类药物使用情况及任何副作用。
地塞米松组的平均VAS评分显著更低(3.5对6. <0.001)。与另一组相比,地塞米松组LC术后恶心和呕吐发生率分别降低46.2%和26.9%(分别为=0.001和0.015)。地塞米松组术后阿片类药物使用量更低,但其差异无统计学意义(=0.3)。
腹腔镜套管针周围腹膜前注射地塞米松可能降低POP强度及PONV发生率。围手术期局部使用皮质类固醇可作为一种有效、可行且廉价的腹腔镜手术镇痛和预防恶心呕吐的方法。